Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I.
Luca D'OnofrioMarta FogolariRocco AmendolaraAntonio SienaRiccardo De FataFlavio DaviniLucia CoraggioCarmen MignognaChiara MorettiErnesto MaddaloniSilvia AngelettiRaffaella BuzzettiPublished in: Diabetes/metabolism research and reviews (2022)
Both T1D and T2D are associated with a reduced early response to vaccination. The serum concentration of Ab significantly reduced over time in both groups, highlighting the relevance of vaccination booster independently from the presence of diabetes. This article is protected by copyright. All rights reserved.